These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 2517713)

  • 1. [Recombinant alfa interferon in the treatment of chronic B and non-A, non-B hepatitis: preliminary results].
    da Silva LC; Carrilho FJ; da Fonseca LE; Farias SM; Faggion P; Granato CF; Vianna MR; Alves VA; Gayotto LC
    Rev Hosp Clin Fac Med Sao Paulo; 1989; 44(5):201-6. PubMed ID: 2517713
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of posttransfusion non-A, non-B acute and chronic hepatitis with human fibroblast beta-interferon: a preliminary report.
    Ohnishi K; Nomura F; Iida S
    Am J Gastroenterol; 1989 Jun; 84(6):596-600. PubMed ID: 2499184
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Therapy of chronic non-A, non-B hepatitis with recombinant interferon alfa and factors that influence the response to the treatment].
    Serejo F; Ramalho F; Marinho R; Raimundo M; Velosa J; de Moura MC
    Acta Med Port; 1991; 4(6):288-92. PubMed ID: 1807091
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Study of the relapse of patients with chronic hepatitis B undergoing first and repeated recombinant interferon-alpha therapy during long-term follow up].
    Liu DL; Luo KX; Feng XR; Fu QX; Hou JL
    Zhonghua Yi Xue Za Zhi; 2007 Jul; 87(26):1840-3. PubMed ID: 17922996
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combination antiviral therapy with ribavirin and interferon alfa in interferon alfa relapsers and non-responders: Italian experience.
    Brillanti S; Miglioli M; Barbara L
    J Hepatol; 1995; 23 Suppl 2():13-5; discussion 15-6. PubMed ID: 8720288
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phase II clinical trial of combined natural interferon-beta plus recombinant interferon-gamma treatment of chronic hepatitis B.
    Musch E; Högemann B; Gerritzen A; Fischer HP; Wiese M; Kruis W; Malek M; Gugler R; Schmidt G; Huchzermeyer H; Gerlach U; Dengler HJ; Sauerbruch T
    Hepatogastroenterology; 1998; 45(24):2282-94. PubMed ID: 9951911
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of chronic non-A,non-B hepatitis with recombinant human alpha interferon. A preliminary report.
    Hoofnagle JH; Mullen KD; Jones DB; Rustgi V; Di Bisceglie A; Peters M; Waggoner JG; Park Y; Jones EA
    N Engl J Med; 1986 Dec; 315(25):1575-8. PubMed ID: 3097544
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recombinant human alpha-interferon therapy for chronic non-A, non-B hepatitis: second report.
    Kakumu S; Arao M; Yoshioka K; Hayashi H; Kusakabe A; Hirofuji H; Kawabe M
    Am J Gastroenterol; 1990 Jun; 85(6):655-9. PubMed ID: 2112882
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Long-term treatment of cryptogenic hepatitis C using recombinant interferon alpha].
    Hopf U; Möller B; König V; Küther S; Lobeck H; Huhn D
    Z Gastroenterol; 1990 Sep; 28(9):453-7. PubMed ID: 2125776
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effectiveness of lamivudine and interferon-alpha combination therapy versus interferon-alpha monotherapy for the treatment of HBeAg-negative chronic hepatitis B patients: a randomized clinical trial.
    Karabay O; Tamer A; Tahtaci M; Vardi S; Celebi H
    J Microbiol Immunol Infect; 2005 Aug; 38(4):262-6. PubMed ID: 16118673
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Therapy for chronic viral hepatitis.
    Alvarez F
    Clin Invest Med; 1996 Oct; 19(5):381-8. PubMed ID: 8889278
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recombinant interferon alfa therapy for chronic hepatitis C. A randomized, double-blind, placebo-controlled trial.
    Di Bisceglie AM; Martin P; Kassianides C; Lisker-Melman M; Murray L; Waggoner J; Goodman Z; Banks SM; Hoofnagle JH
    N Engl J Med; 1989 Nov; 321(22):1506-10. PubMed ID: 2509917
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pilot study of a short course of ribavirin and alpha interferon in the treatment of chronic active hepatitis C not responding to alpha-interferon alone.
    Scotto G; Fazio V; Tantimonaco G
    Ital J Gastroenterol; 1996 Dec; 28(9):505-11. PubMed ID: 9131395
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pilot study of ribavirin and interferon-beta for chronic hepatitis B.
    Kakumu S; Yoshioka K; Wakita T; Ishikawa T; Takayanagi M; Higashi Y
    Hepatology; 1993 Aug; 18(2):258-63. PubMed ID: 8340055
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pretransplantation interferon treatment and recurrence of hepatitis B virus infection after liver transplantation for hepatitis B-related end-stage liver disease.
    Marcellin P; Samuel D; Areias J; Loriot MA; Arulnaden JL; Gigou M; David MF; Bismuth A; Reynes M; Bréchot C
    Hepatology; 1994 Jan; 19(1):6-12. PubMed ID: 8276368
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of chronic hepatitis B (HBeAg-HBV DNA-positive) with lymphoblastoid alpha interferon with or without corticosteroids: short- and long-term follow-up.
    Zavaglia C; Bottelli R; Bellati G; Asti L; Mondazzi L; Iamoni G; Zanetti A; Tanzi E; Fesce E; Gelosa F; Maggi G; Ideo G
    Ital J Gastroenterol; 1996; 28(6):324-31. PubMed ID: 8891847
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lymphoblastoid interferon alfa with or without steroid pretreatment in children with chronic hepatitis B: a multicenter controlled trial.
    Gregorio GV; Jara P; Hierro L; Diaz C; de la Vega A; Vegnente A; Iorio R; Bortolotti F; Crivellaro C; Zancan L; Daniels H; Portmann B; Mieli-Vergani G
    Hepatology; 1996 Apr; 23(4):700-7. PubMed ID: 8666320
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Significance of anti-interferon-alpha2 and sICAM-1 activities in the sera of viral hepatitis B and C patients treated with human recombinant interferon-alpha2.
    Stancek D; Fuchsberger N; Oltman M; Schmeisser H; Kontsek P; Jahnová E; Hajnická V
    Acta Virol; 2001; 45(5-6):287-92. PubMed ID: 12083327
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Individualization of interferon therapy using serum hepatitis B virus DNA to reduce viral relapse in patients with chronic hepatitis B: a randomized controlled trial.
    Chung YH; Song BC; Lee GC; Shin JW; Ryu SH; Jung SA; Yoo K; Lee HC; Lee YS; Suh DJ
    Eur J Gastroenterol Hepatol; 2003 May; 15(5):489-93. PubMed ID: 12702905
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interferons in the management of viral hepatitis.
    Zein NN
    Cytokines Cell Mol Ther; 1998 Dec; 4(4):229-41. PubMed ID: 10068057
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.